"Anne Pritchett, senior vice president with the industry group PhRMA, said that lifting patent waivers for COVID vaccines could backfire in the next global health crisis.
"We don’t want to be deterring innovation by saying to companies, ‘There’s no incentive for you to invest in that, because we’re just going to take your IP and give it away,'” she said.
Countries in the EU, plus Switzerland and the U.K., support that view."
